V

Visionary Venture Fund

8 employees

A venture capital fund that invests in the future of ophthalmology.

Investor insights

Sectors invested in

Health Care14
Medical9
Medical Device8
Biotechnology7
Pharmaceutical6
Therapeutics4
Biopharma3
Ophthalmology3
Information Technology2
Clinical Trials2
Market Research2
Chemical Engineering2
Wellness2
Drug delivery2
Uveitis2
DME2
DR2
AMD2
Eye diseases2
Customized Processed Corneal Tissue1

Funding rounds participated in

$13M sweet spot round size

Most of their 19 investments are in rounds between $4.5M and $22M

Investor type

Micro VC

Basic info

Industry

venture capital and private equity principals

Date founded

2016

Investments made

O

ONL Therapeutics raised $15M on March 8, 2023

Investors: Bios Partners, 凯泰资本, Michigan Capital Network and Visionary Venture Fund

R

RE-VANA raised $12M on November 30, 2022

Investors: InFocus Capital Partners, -, Fund NI, Techstart Ventures LLP and Visionary Venture Fund

I

Iantrek Inc raised $23M on August 30, 2022

Investors: Sectoral Asset Management and Visionary Venture Fund

A

Aurion Biotech raised $120M on April 12, 2022

Investors: -, Flying L Partners and Visionary Venture Fund

U

Undisclosed raised $45M on August 10, 2021

Investors: SC Master Fund, Bluestem Capital Co, Longitude Capital, Medicxi, RA Capital Management, L.P. and Visionary Venture Fund

O

ORASIS PHARMACEUTICALS raised $30M on September 10, 2020

Investors: Maverick Ventures, Bluestem Capital Co, LifeSci Venture Partners and Visionary Venture Fund

T

TearClear raised $22M on August 11, 2020

Investors: Bluestem Capital Co, Flying L Partners and Visionary Venture Fund

R

RE-VANA raised $3.3M on June 2, 2020

Investors: InFocus Capital Partners, Clarendon Fund Managers, -, Techstart Ventures LLP and Visionary Venture Fund

T

Tarsus Pharmaceuticals, Inc. raised $60M on January 8, 2020

Investors: Aperture Venture Partners, Frazier Healthcare Partners, Flying L Partners and Visionary Venture Fund

S

Surface Ophthalmics, Inc. raised $21M on July 11, 2018

Investors: Visionary Venture Fund

FAQ